Share chart Summit Therapeutics Inc.
Extended chart
Simple chart
About Summit Therapeutics Inc.
Summit Therapeutics Inc., биофармацевтическая компания, занимается исследованиями и разработками в основном в области лечения онкологических заболеваний в США и Великобритании. Ассортимент продукции компании включает SMT-738, новый класс прецизионных антибиотиков для лечения, который находится на доклинической стадии для лечения инфекций с множественной лекарственной устойчивостью, которые в первую очередь включают инфекции Enterobacteriaceae, устойчивые к карбапенемам. Он имеет сотрудничество и лицензионное соглашение с Akeso, Inc. more details| IPO date | 2015-03-05 |
|---|---|
| ISIN | US86627T1088 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.summittxinc.com |
| Цена ао | 19.89 |
| Change price per day: | -36.06% (36.7) |
|---|---|
| Change price per week: | -4.65% (24.61) |
| Change price per month: | +17.97% (19.89) |
| Change price per 3 month: | -1.24% (23.76) |
| Change price per half year: | +5.51% (22.24) |
| Change price per year: | +507.9% (3.86) |
| Change price per 3 year: | +1 115.8% (1.93) |
| Change price per 5 year: | +890.08% (2.37) |
| Change price per year to date: | +26.36% (18.57) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Blackrock Inc. | 9759383 | 1.39 |
| Vanguard Group Inc | 7014982 | 1 |
| Geode Capital Management, LLC | 3085666 | 0.44 |
| State Street Corporation | 2456168 | 0.35 |
| Northern Trust Corporation | 1108089 | 0.16 |
| Charles Schwab Investment Management, Inc. | 953846 | 0.14 |
| Morgan Stanley | 704272 | 0.1 |
| Steward Partners Investment Advisory, LLC | 600000 | 0.09 |
| Nuveen Asset Management, LLC | 565624 | 0.08 |
| Alps Advisors Inc. | 532406 | 0.08 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| Future Tech ETF | 1.71443 | 426.34 | 0.8416 |
| Principal Healthcare Innovators ETF | 1.71443 | 618.5 | 0.8416 |
| iShares Morningstar Small-Cap Growth ETF | 0.04561 | 3.67 | 0.72598 |
| iShares Morningstar Small-Cap Value ETF | 0.04402 | -3.08 | 2.50476 |
| iShares Morningstar Small-Cap ETF | 0.04321 | 391.25 | 1.60498 |
| 0.71 | 287.34 | 1.3 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Robert W. Duggan | Co-CEO & Executive Chairman | N/A | 1944 (81 year) |
| Prof. Dame Kay Davies DBE, FRS CBE | Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor | N/A | 1951 (74 years) |
| Ms. Abby Guzman Murphy | Head of Human Resources | N/A | |
| Ms. Divya Chari | Head of Global Clinical Operations | N/A | 1968 (57 years) |
| Mr. Dave Gancarz | Chief Business & Strategy Officer | N/A | |
| Dr. Mahkam Zanganeh D.D.S., M.B.A. | Co-CEO, President & Director | 657.81k | 1970 (55 years) |
| Mr. Manmeet Singh Soni | COO, CFO & Director | 591.5k | 1978 (47 years) |
| Dr. Betty Y. Chang Ph.D. | Head of Research, Oncology & Inflammation | N/A | |
| Mr. Bhaskar Anand | Chief Accounting Officer & Head of Finance | 1978 (47 years) | |
| Dr. Fong Clow | Chief Biometrics Officer |
Address: United States, Cambridge. MA, 2882 Sand Hill Road. Suite 106 - open in Google maps, open in Yandex maps
Website: https://www.summittxinc.com
Website: https://www.summittxinc.com
